ANKEBIO ANTI-PD1 PRODUCT
【INN】Recombinant anti-PD1 Humanized Monoclonal Antibody Injection
【Indication】Advanced cancers
【Protein Type】Monoclonal antibody
【Mechanism of Action】
A human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti- tumor immune response.
